$Pedevco(PED)$As the chart shows, support is provided at $1.57, the price at which an offering was made, moreover also when the CEO purchased $500K worth of shares, which can only show two things:1. Strong resistance supporting at $1.57, since most insiders own it, perhaps this is support provided by the insiders2. It is going to rebound fast following next few days due to the chart patterns which show strong bullish patterns every time the price hits $1.57!!

$Toughbuilt Industries, Inc.(TBLT)$It’s just the beginning guys!! Finally TBLT is making a comeback, although Q2 and Q3 wasn’t so well, it’s sales has rapidly increased y-o-y through Amazon the past 2 quarters! Remember last quarter that TBLT skyrocketed to $1.20 and above due to its sales from Amazon, so what’s not to say it will also make a bullish move for the next few days due toits sales from Amazon!! Although entered this at around 0.73, I believe it will push through past $1,I will only sell this beyond $1.23, even better, I shall sell it at $1.70 around there only!!! Look at thepositive aspects of Toughbuilt guys! If you look at weekly charts it suggests a squeeze to come soon, because of the textbook bull chart. It’s only amatter of time, wh

$Pedevco(PED)$Come on guys push!! Don’t let the shorties bring the stock below $1.57, we must win the battle 🦍 🦍 ‼️

$Pedevco(PED)$This is a textbook example of a bullish breakout pattern!! The volume seems good and intraday trading has been going well for the past 2 weeks of this stock since it’s first breakout to $2.42, and in my opinion, we’re merely few days away from the next breakout, I predict a $3 target, then the shorties will start to borrow shares as the price inches towards $3 and bring the stock down. And perhaps there could possiblybe another jump to $5, all lies in the hands of buyers vs. shorties, as the shorties don’t let the price rise after a certain target price is reached. Firstly, these price targets I’m mentioning are based on Will Meade’s tweets regarding Pedevco, furthermore the fact that the CEO internally bought $500K worth of shares is an

$Meta Materials Inc.(MMAT)$I feel like the reverse stock split is for the company to provide moreshares under the hood, or maybe cover losses, then now maybe the insiders are selling off or hedge funds, this is just a speculation, do not take it as an inside news or fact as I myself am clueless and just trying to understand why they are trying to drive the price down after merger just like when price went to $10 before and they brought it to $5. They also haven’t paid out dividends which were claimed to be paid by torchlight last week Friday, maybe this sellout is our dividend that’s coming to us 🤷‍♂️

$Metamaterial Inc.(MMATF)$If I buy 100 MMATFtoday before closing will I get 300 TRCH? Is the spin-off already done for MMATF or yet to do? 

$Orphazyme A/S(ORPH)$Orphazyme A/SCompany announcement No. 19/2021Company Registration No. 32266355Copenhagen, Denmark, June 24, 2021 – Orphazyme A/S (ORPHA.CO; ORPH) (“the Company”), a late-stage biopharmaceutical company pioneering the heat shock protein response for the treatment of rare diseases, hereby announces the receipt of notification pursuant to Section 38 of the Danish Capital Markets Act from Aescap Venture Management B.V, that as of June 16, 2021, Aescap Venture Management B.V indirectly holds shares corresponding to less than 5% of the total share capital and voting rights in the Company.

$Torchlight Energy Resources(TRCH)$what’s the dividend haha?

$BlackBerry(BB)$Looking forward towards earnings report‼️

$Orphazyme A/S(ORPH)$Looking towards the future we can see that Orphazyme has huge growth capabilities which can be interpreted from the financial data and the pentagon chart provided byTiger. Like I said in my last featured post, IT’S JUST THE STARTING!! Why? Because if you go through the report released by Orphazyme on last Friday June 18th around 1am in U.S time, they have mentioned in the forward looking statement that the company is planning to reshuffle its efforts into the use of arimoclomol for NPC, but why though? This is because FDA ‘DID NOT REJECT’ Arimoclomol for treatment of NPC, they rather mentioned the lack of evidence therefore what the company intends to do is indeed gather more evidences, data and proof that Arimoclomol works for N